financetom
Business
financetom
/
Business
/
S&P lowers Nissan's outlook to negative, affirms BB+ ratings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
S&P lowers Nissan's outlook to negative, affirms BB+ ratings
Jan 14, 2025 12:51 AM

TOKYO, Jan 14 (Reuters) - S&P Global Ratings revised

Nissan Motor's ( NSANF ) credit outlook to negative from stable

and affirmed its BB+ rating, as it expected it would take the

Japanese automaker longer to improve its business performance.

"The negative outlook reflects our view that the company's

creditworthiness will continue to deteriorate if profitability

does not improve and positive free cash flow is not secured,"

S&P said in a statement.

Nissan ( NSANF ) has increased sales incentives in a bid to correct

high inventory levels, which have risen due to a slowdown in car

sales in North America, the company's main market, S&P said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell
BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell
Oct 2, 2024
08:46 AM EDT, 10/01/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Tuesday that a breast cancer patient treated in a phase 2 study of the company's Bria-IMT regimen showed a dramatic anti-tumor response. The company said treatment with its Bria-IMT regimen resulted in complete resolution of right temporal lobe brain metastasis in the patient with eye-bulging metastatic breast...
Paychex Fiscal Q1 Adjusted Earnings, Revenue Rise
Paychex Fiscal Q1 Adjusted Earnings, Revenue Rise
Oct 2, 2024
08:46 AM EDT, 10/01/2024 (MT Newswires) -- Paychex ( PAYX ) reported fiscal Q1 adjusted earnings Tuesday of $1.16 per diluted share, up from $1.14 a year earlier. Analysts surveyed by Capital IQ expected $1.14. Revenue for the quarter ended Aug. 31 was $1.32 billion, compared with $1.29 billion a year earlier. Analysts polled by Capital IQ expected $1.31 billion....
Health insurers unveil Medicare Advantage plans for 2025
Health insurers unveil Medicare Advantage plans for 2025
Oct 2, 2024
Oct 1 (Reuters) - Health insurers Cigna ( CI ), CVS Health ( CVS ), Humana and Centene ( CNC ) on Tuesday released details on their government-backed health insurance plans for next year for people aged 65 and above. The announcements come ahead of the beginning of enrollment for Medicare Advantage plans on October 15, which will continue through...
Pactiv Evergreen Completes $110 Million Sale of Paper Plants to Suzano
Pactiv Evergreen Completes $110 Million Sale of Paper Plants to Suzano
Oct 2, 2024
08:49 AM EDT, 10/01/2024 (MT Newswires) -- Pactiv Evergreen ( PTVE ) said Tuesday it has completed the $110 million sale of its Pine Bluff, Ark., paper mill and Waynesville, N.C., extrusion facility to Brazilian paper producer Suzano. Pactiv President and Chief Executive Michael King said the sale will smooth the company's transition to a capital-light business model and is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved